Global Hepatitis Delta Virus (HDV) Infection Market Strategic Research Report

Scope of the Report

The global Hepatitis Delta Virus (HDV) Infection market size is predicted to grow from US$ 2,013 million in 2025 to US$ 13,010 million in 2032; it is expected to grow at a CAGR of 31.1% from 2026 to 2032.

Hepatitis D, also known as delta hepatitis, is a liver infection caused by the Hepatitis D virus (HDV). It is considered a satellite virus, as it requires the presence of the Hepatitis B virus (HBV) to replicate and cause infection. HDV infects individuals either as a co-infection with HBV or as a superinfection in those already infected with HBV. Hepatitis D is caused by the HDV, which can only infect individuals already infected with HBV. HDV can spread through contact with infected blood or body fluids, similar to HBV transmission routes. Injection drug use, exposure to infected blood, or unprotected sexual contact with an HBV/HDV-infected person are common risk factors for acquiring Hepatitis D.

The increasing global prevalence of HDV infection is a significant market driver that is boosting the Market CAGR. HDV infection, which occurs along with hepatitis B virus (HBV) infection, is considered the most severe form of viral hepatitis, resulting in increased morbidity and fatality rates. The World Health Organization (WHO) estimates that over 15-20 million people globally are chronically infected with HDV. This growing incidence of HDV infection highlights the critical need for improved diagnoses, therapies, and preventive measures, which will drive market expansion.

This report presents a comprehensive overview of the global Hepatitis Delta Virus (HDV) Infection market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Acute Hepatitis D
• Chronic Hepatitis D

Segment by Application

• Clinic
• Hospital
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Hepatitis Delta Virus (HDV) Infection market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Clinic, Hospital, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact